Skip to main content
Clinical Trials/NL-OMON56538
NL-OMON56538
Not yet recruiting
Not Applicable

Biomarker signature discovery study to determine acute bacterial respiratory tract infection. - BIOSIG

evels Diagnostics0 sites300 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
evels Diagnostics
Enrollment
300
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
evels Diagnostics

Eligibility Criteria

Inclusion Criteria

  • RTI group (250 patients) \-Mentally competent \& adult, bacterial or viral
  • respiratory tract infection) Controlgroup (50 patients): \-Mentally competent \&
  • adult, patients without clinical signs of a respiratory tract infection

Exclusion Criteria

  • RTI group: Undefined (unable to determine and identify the pathogenic origin)
  • respiratory tract infection.
  • Control group: fever or other symptoms known to RTIs within 14 days prior to

Outcomes

Primary Outcomes

Not specified

Similar Trials